Monash IVF Group Limited provided earnings guidance for the six months ending December 31, 2021 and revenue guidance for the second half of 2022. The company's NPAT before certain non-regular items for the six-month period ending 31 December 2021 is expected to be approximately $13.0 million, as compared to $12.0 million in the prior comparative period. The Group is confident revenue and earnings can grow in second half of 2022, subject to any adverse impact from the ongoing Pandemic.